“borderline significant”

For the MTRR A66G polymorphism, we detected a borderline significant interaction between this polymorphism and overweight/obesity on serum HDL-C levels ( P = 0.050, Table 3 ).

The data is borderline significant at p<0.05 for the difference between the median of 56 pairs of flies.

Multiple logistic regression analysis of the remaining predictors, including anti-dsDNA, C4, ESR, and clinically detected synovitis, showed clinically detected synovitis had the most significant association with and the highest odds of US-detected inflammatory arthritis in the final model (aOR = 142.35, 95% confidence interval [CI] 6.55–3093.96; p = 0.002), as well as a borderline significant association with ESR levels (aOR = 1.04, 95% CI 1.00–1.08; p = 0.05).

However, it is important to note that only three studies included in the analysis had high quality, which accounted for 19.01% of the weight of the aggregated meta-analysis results, and the findings in the moderate-quality studies were borderline significant ( p = 0.05).

A borderline significant difference was observed between subgroups based on stimulant type ( p = 0.05).

At 12 months, there was a borderline significant increase in fT4 levels compared to baseline (p=0.05), but values remained within normal limits (0.8–1.8 ng/dL).

Outcome percentage SDAI/CDAI/Boolean remission Targeting SDAI/CDAI-LDA significantly improved the percentage of patients in SDAI/CDAI/Boolean remission compared with both DAS-LDA and DAS-remission targets, after 1 year (borderline significant for DAS-LDA) and 2–3 years (year 1: 34% p=0.05 and 35% p=0.03 for comparison to DAS-LDA and DAS-remission respectively, year 2–3: 31% p=0.0002 and 36% p<0.0001) (see figure 2D and online supplemental tables S2 and S3 ).

The USG spot samples (morning: 1.018 [1.008—1.028] and afternoon: 1.011 [1.000–1.026]) were borderline significant with p = 0.05).

Readmission rates showed a borderline significant difference across continence groups ( p = 0.05), whereas complication severity according to Clavien–Dindo classification did not differ significantly.

In the univariate analyses, the degree of DFA stenosis was a significant predictor for major amputation ( p = 0.04) and a borderline significant predictor of improvement of the ankle brachial index ( p = 0.05).

In the mixed dentition subgroup, a borderline significant difference was observed for DMFT values ( p = 0.05).

Differences were considered significant when p <0.004, and borderline significant when p <0.05.

For hamstrings, the pooled effect was smaller and borderline significant (SMD = 1.48 [− 0.01, 2.97], Z = 1.94, p = 0.05; I 2 = 81%), indicating variability across studies.

The cost contribution attribute was again not significant for the parent sample but was borderline significant for the child sample, who showed preference for lower cost contribution ( β -coefficient = −0.0095 [ P = 0.050; 95 % bootstrapped CI = −0.013 to −0.009]).

Employment status showed a borderline significant association with satisfaction ( χ 2 = 21.00, p = 0.050), whereas age (p = 0.855), gender (p = 0.687), income (p = 0.088), education (p = 0.740), and marital status (p = 0.875) were not significant predictors.

The four-way interaction was borderline significant ( p = 0.050).

Furthermore, SGB also demonstrated a borderline significant reduction in pain scores at 24 hours (MD = −0.48; 95% CI = −0.96, −0.01; P = 0.05; I 2 = 67%, Figure 7 ).

The HHIP and DOT1L interactions are borderline significant (just below p<0.05) but for the former there is also a possible biological explanation (see Discussion).

Importantly, the Charlson Comorbidity Index showed a borderline significant association with longer antibiotic duration (β = 4.57, 95% CI: −0.05 to 9.20, p = 0.05). 3.6.

There was a borderline significant decrease in risk (0.01<P<0.05) with low dose unopposed equine oestrogen, low dose unopposed non-equine oestrogen, high dose unopposed non-equine oestrogen, and continuous high dose non-equine.

Cat ownership showed a borderline significant association with seropositivity (OR = 3.79, p = 0.05).

BMI showed a borderline significant correlation with C4 (ρ = 0.343, p = 0.050).

Children in group age 15 to 16 were two times more likely to have metabolic syndrome than those in group age 13 to 14 (AOR = 2.1, 95% CI: 1.0, 4.4) and this difference was borderline significant (p = 0.05).

Cancers of the oral cavity and pharynx showed a borderline significant association in the unadjusted model (p = 0.05) but after adjustment for confounding the trend in relation to Ab levels was positive but not statistically significant (OR for medium Ab = 1.1, and high Ab = 1.5 p = 0.13).

When using weight gain between six and 12 months and BMI as continuous variables, the same pattern was seen, except for only a borderline significant association in the multivariable version (βeta ( β ) 0.048, (SE), 0.025, p = 0.05).